Functional analysis of the human complement receptor 2 (CR2/CD21) promoter: Characterization of basal transcriptional mechanisms

被引:21
|
作者
Ulgiati, D
Pham, C
Holers, VM
机构
[1] Univ Colorado, Hlth Sci Ctr, Div Rheumatol, Dept Immunol, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Div Rheumatol, Dept Med, Denver, CO 80262 USA
[3] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
来源
JOURNAL OF IMMUNOLOGY | 2002年 / 168卷 / 12期
关键词
D O I
10.4049/jimmunol.168.12.6279
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human complement receptor (CR) type 2 (CR2/CD21) is a 145-kDa membrane protein encoded within the regulators of complement activation gene cluster localized on human chromosome 1q32. Understanding the mechanisms that regulate CR2 expression is important because CR2 is expressed during specific stages of B cell development, and several lines of evidence suggest a role for altered CR2 function or expression in a number of autoimmune diseases. Additionally, even modest changes in CR2 expression are likely to affect relative B cell responses. In this study we have delineated the transcriptional requirements of the human CR2 gene. We have studied the human CR2 proximal promoter and identified sites important for controlling the level of transcription in CR2-expressing cells. We have determined that four functionally relevant sites lie within very close proximity to the transcriptional initiation site. These sites bind the transcription factors USF1, an AP-2-like transcription factor, and Sp1.
引用
收藏
页码:6279 / 6285
页数:7
相关论文
共 50 条
  • [31] The structural basis for complement receptor type 2 (CR2, CD21)-mediated alternative pathway activation of complement: studies with CR2 deletion mutants and vaccinia virus complement-control protein-CR2 chimeras
    Johnson, AA
    Rosengard, AM
    Skjodt, K
    Ahearn, JM
    Leslie, RGQ
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1999, 29 (12) : 3837 - 3844
  • [32] Human complement receptor (CR2/CD21) is a receptor for DNA: Implications for its roles in the immune response and the pathogenesis of systemic lupus erythematosus (SLE)
    Asokan, R
    Lyubchenko, T
    Szakonyi, G
    Aramowizc, K
    Boackle, S
    Chen, XJ
    Holers, VM
    FASEB JOURNAL, 2005, 19 (04): : A886 - A886
  • [33] B cell expression of the complement receptor 2 (CR2/CD21) constitutes a novel biomarker for COVID-19 severity
    Marcos-Jimenez, Ana
    Delgado-Wick, Pablo
    Diaz-Fernandez, Paula
    Montes, Nuria
    Fernandez-Lazaro, Iris
    Andreu-Martinez, Rosa M.
    Lopez, Noelia
    Cuesta-Mateos, Carlos
    Munoz-Calleja, Cecilia
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 1680 - 1680
  • [34] An intronic silencer regulates B lymphocyte cell and stage specific expression of the human complement receptor type 2 (CR2,CD21) gene.
    Makar, KW
    Pham, CT
    Dehoff, M
    OConnor, S
    Jacobi, S
    Holers, VM
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 980 - 980
  • [35] Role of complement receptors type 2 (CR2/CD21) and 1 (CR1/CD35) in murine lupus
    Holers, VM
    Boackle, SA
    Jiang, N
    Jeong, CH
    Molina, H
    MOLECULAR IMMUNOLOGY, 1998, 35 (6-7) : 355 - 355
  • [36] Relative Impact of Complement Receptors CD21/35 (Cr2/1) on Scrapie Pathogenesis in Mice
    Kane, Sarah J.
    Swanson, Eric
    Gordon, Elizabeth O.
    Rocha, Savannah
    Bender, Heather R.
    Donius, Luke R.
    Aguzzi, Adriano
    Hannan, Jonathan P.
    Zabel, Mark D.
    MSPHERE, 2017, 2 (06):
  • [37] Characterization of C3dg binding to a recess formed between short consensus repeats 1 and 2 of complement receptor type 2 (CR2; CD21)
    Prodinger, WM
    Schwendinger, MG
    Schoch, J
    Köchle, M
    Larcher, C
    Dierich, MP
    JOURNAL OF IMMUNOLOGY, 1998, 161 (09): : 4604 - 4610
  • [38] Characterization of the CR2/CD21 proximal promoter: Functional role for AP1/AP2 sites and two adjacent Ebox motifs.
    Ulgiati, D
    Virasch, N
    Holers, VM
    FASEB JOURNAL, 2000, 14 (06): : A1035 - A1035
  • [39] An intronic silencer regulates B lymphocyte cell- and stage-specific expression of the human complement receptor type 2 (CR2, CD21) gene
    Makar, KW
    Pham, CTN
    Dehoff, MH
    O'Connor, SM
    Jacobi, SM
    Holers, VM
    JOURNAL OF IMMUNOLOGY, 1998, 160 (03): : 1268 - 1278
  • [40] Increased B cell deletion and significantly reduced auto-antibody titre due to premature expression of human complement receptor 2 (CR2, CD21)
    Pappworth, Isabel Y.
    Kulik, Liudmila
    Haluszczak, Catherine
    Reuter, Jason W.
    Holers, V. Michael
    Marchbank, Kevin J.
    MOLECULAR IMMUNOLOGY, 2009, 46 (06) : 1042 - 1049